Impact of hemoglobin on plasma Pro-B-type natriuretic peptide concentrations in the general population

Clinical Chemistry

Volumn 53, Issue 11, 2007, Pages 1921-1927

  Nybo, Mads ^a   Benn, Marianne ^a   Mogelvang, Rasmus ^a   Jensen, Jan Skov ^a   Schnohr, Peter ^a   Rehfeld, Jens F ^a   Goetze, Jens Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN;

ADULT; AGE; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; DENMARK; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; SEX DIFFERENTIATION; STROKE;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PLASMA; PROTEIN PRECURSORS; REFERENCE VALUES; REGRESSION ANALYSIS; VENTRICULAR FUNCTION, LEFT;

EID: 35649017096     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.089391     Document Type: Article

References (39)

1. De Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-22.
2. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-82.
3. Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, et al. The influence of age, sex, and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003;89:745-51.
4. Goetze JP, Mogelvang R, Maage L, Scharling H, Schnohr P, Sogaard P, et al. Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction. Eur Heart J 2006;27:3004-10.
5. Brucks S, Little WC, Chao T, Rideman RL, Upadhya B, Wesley-Farrington D, et al. Relation of anemia to diastolic heart failure and the effect on outcome. Am J Card 2004;93:1055-7.
6. Mockel M, Muller R, Vollert JO, Muller C, Carl A, Peetz D, et al. Role of N-terminal pro-B-type natriuretic peptide in risk stratification in patients presenting in the emergency room. Clin Chem 2005;51:1624-31.
7. Nybo M, Kristensen SR, Mickley H, Jensen JK. The influence of anaemia on stroke prognosis and its relation to N-terminal probrain natriuretic peptide. Eur J Neurol 2007;14:477-82.
8. Wu AH, Omland T, Wold Knudsen C, McCord J, Nowak RM, Hollander JE, et al.; Breathing Not Properly Multinational Study Investigations. Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: a substudy from the Breathing Not Properly (BNP) Multinational Study. Am J Hematol 2005;80:174-80.
9. Willis MS, Lee ES, Grenache DG. Effect of anaemia on plasma concentrations of NT-proBNP. Clin Chim Acta 2005;358:175-81.
10. Knudsen CW, Clopton P, Westheim A, Klemsdal TO, Wu AH, Due P, et al. Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the Breathing Not Properly multinational study. Ann Emerg Med 2005;45:573-80.
11. Tsuji H, Nishino N, Kimura Y, Yamada K, Nukui M, Yamamoto S, et al. Haemoglobin level influences plasma brain natriuretic peptide concentration. Acta Cardiol 2004;59:527-31.
12. Wold Knudsen C, Vik-Mo H, Omland T. Blood haemoglobin is an independent predictor of B-type natriuretic peptide (BNP). Clin Sci 2005;109:69-74.
13. Milman N, Agger OA, Nielsen OJ. Iron supplementation during pregnancy: effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo controlled study in 207 Danish women. Dan Med Bull 1991;38:471-6.
14. DeMaeyer E, Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat Quart 1985;38:302-16.
15. Beghe C, Wilson A, Ershler WB. Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med 2004;116(Suppl 7A):S3-10.
16. Appleyard M, Hansen AT, Schnohr P, Jensen G, Nyboe J. The Copenhagen City Heart Study. A book of tables with data from the first examination (1976-78) and a five-year follow-up (1981-83). Scand J Soc Med 1989;170:1-160.
17. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M. The Copenhagen City Heart Study. Eur Heart J 2001;3(Suppl H):1-83.
18. Blanc B, Finch CA, Hallberg L. Nutritional anaemias. WHO Tech Rep Ser 1968;405:1-40.
19. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005;18:319-32.
20. Coyne D. Iron indices: what do they really mean? Kidney Intern Suppl 2006;101:S4-8.
21. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocard 1989;2:358-67.
22. Berning J, Steensgaard-Hansen F. Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarction. Am J Cardiol 1990;65:567-76.
23. Berning J, Rokkedal Nielsen J, Launbjerg J, Fogh J, Mickley H, Andersen PE. Rapid estimation of left ventricular ejection fraction in acute myocardial infarction by echocardiographic wall motion analysis. Cardiology 1992;80:257-66.
24. Kober L, Torp-Pedersen C, Carlsen J, Videbaek R, Egeblad H. An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac Evaluation. Eur Heart J 1994;15:1616-20.
25. Goetze JP, Kastrup J, Pedersen F, Rehfeld JF. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 2002;48:1035-42.
26. Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PH, Newman AB, et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Int Med 2005;165:2214-20.
27. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12065 patients with new-onset heart failure. Circulation 2003;107:223-5.
28. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-6.
29. Collins AJ. Influence of target hemoglobin in dialysis patients on morbidity and mortality. Kidney Intern Suppl 2002;80:44-8.
30. Dexter F, Hindman BJ. Effect of hemoglobin concentration on brain oxygenation in focal stroke: a mathematical modelling study. Br J Anaesth 1997;79:346-51.
31. Goetze JP, Gore A, Moller CH, Steinbruchei DA, Rehfeld JF, Nielsen LB. Acute myocardial hypoxia increases BNP gene expression. FASEB J 2004;18:1928-30.
32. Luo Y, Jiang C, Belanger AJ, Akita GY, Wadsworth SC, Gregory RJ, et al. A constitutively active HIF-1α/VP16 hybrid factor activates expression of the human B-type natriuretic peptide gene. Mol Pharmacol 2006;69:1953-62.
33. Muscari A, Berzigotti A, Bianchi G, Giannoni C, Ligabue A, Magalotti D, et al. Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of haematocrit and hepatic steatosis. Eur J Heart Fail 2005;8:468-76.
34. Kanda H, Kita Y, Okamura T, Kadowaki T, Yoshida Y, Nakamura Y, et al. What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population? J Hum Hypertens 2005;19:165-72.
35. Rehfeld JF, Goetze JP. The post-translational phase of gene expression: new possibilities in molecular diagnosis. Curr Mol Med 2003;3:25-38.
36. Giuliani I, Rieunier F, Larue C, Delagneau JF, Granier C, Pau B, et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 2006;52:1054-61.
37. Liang F, O'Rear J, Schellenberger U, Tai L, Lasecki M, Schreiner GF, et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol 2007;49:1071-8.
38. Lam CS, Burnett JC Jr, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J Am Coll Cardiol 2007;49:1193-202.
39. Schellenberger U, O'Rear J, Guzzetta A, Jue RA, Protter AA, Pollitt NS. The precursor to B-type natriuretic peptide is an 0-linked glycoprotein. Arch Biochem Biophys 2006;451:160-6.